SECOND AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT PRECISION THERAPEUTICS INC.Precision Therapeutics Inc. • February 12th, 2019 • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
THIS SECOND AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received in connection with the funding of all or a portion of the purchase price of that certain second amended and restated promissory note in the principal amount of $1,620,000.00 on February 6, 2019 issued by Precision Therapeutics Inc., a Delaware corporation (the “Company”), to the Holder (as defined below) (the “Note”), Carl Schwartz (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from the Company during the Exercise Period (as defined below) such numbers of shares of Common Stock (as defined below) as are set forth herein and in the attached Schedule 1, as it may be amended from time to time (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the
FORBEARANCE AGREEMENTForbearance Agreement • February 12th, 2019 • Precision Therapeutics Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Nevada
THIS FORBEARANCE AGREEMENT (this “Agreement”) is made and entered as of February 7, 2019 (the “Effective Date”), by and between PRECISION THERAPEUTICS INC., a Delaware corporation (“AIPT”), and Peak One Opportunity Fund, LP, a Delaware limited partnership (“Peak One”).
FORBEARANCE AGREEMENTForbearance Agreement • February 12th, 2019 • Precision Therapeutics Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Kansas
THIS FORBEARANCE AGREEMENT (this “Agreement”) is made and entered as of February 7, 2019 (the “Effective Date”), by and between PRECISION THERAPEUTICS INC., a Delaware corporation (“AIPT”), and L2 CAPITAL, LLC, a Kansas limited liability company (“L2”).
